Will Trust in the Johnson & Johnson Vaccine Recover? Europe ’s AstraZeneca Experience Suggests Not
When the U.S. Food and Drug Administration and Centers for Disease Control and Prevention recommended stopping use of the Johnson & Johnson/Janssen COVID-19 vaccine on April 13, they declared the action a “pause”—a brief intermission as the government investigates a possible link between the vaccine and blood clots in a small number of recipients. The agencies may lift that recommendation as soon as this week, and vaccination with the Pfizer-BioNTech and Moderna shots has continued. However temporary it might be, a recent YouGov/Economist survey suggests that the J&J pause has already hurt U.S. pu...
Source: TIME: Health - April 20, 2021 Category: Consumer Health News Authors: Tara Law Tags: Uncategorized COVID-19 Source Type: news

Coronavirus (COVID-19) Infection Survey: antibody and vaccination data for the UK: 14 April 2021, ONS
Antibody and vaccination data by UK country and regions in England from the Coronavirus (COVID-19) Infection Survey. This survey is being delivered in partnership with University of Oxford, University of Manchester, Public Health England and Wellcome Trust. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - April 19, 2021 Category: Consumer Health News Source Type: news

Cochrane PaPaS seeks full-time Systematic Reviewer - remote
Closing date: 28 April 2021Location: remote (home-working)The Cochrane Pain, Palliative and Supportive Care (Cochrane PaPaS) Review Group is looking for an experienced Systematic Reviewer to undertake high quality, priority Cochrane systematic reviews for publication in the Cochrane Library.The focus of PaPaS is studies of interventions for acute pain, chronic pain, headache and migraine, palliative care for those with life-limiting disease or illness, and supportive care of patients and significant others living with serious illness.The candidate will work with a multidisciplinary team to undertake new priority reviews, o...
Source: Cochrane News and Events - April 19, 2021 Category: Information Technology Authors: Lydia Parsonson Source Type: news

Covid: trial to study effect of immune system on reinfection
Oxford scientists will track whether participants are reinfected when re-exposed to coronavirusCoronavirus – latest updatesSee all our coronavirus coverageThe immune response needed to protect people against reinfection with the coronavirus will be explored in a new human challenge trial, researchers have revealed.Human challenge trials involve deliberately exposing healthy people to a disease-causing organism in a carefully controlled manner, and have proved valuable in understanding and tackling myriad conditions from malaria to tuberculosis and gonorrhoea.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - April 19, 2021 Category: Science Authors: Nicola Davis Science correspondent Tags: Medical research Coronavirus Infectious diseases Microbiology Science University of Oxford UK news Source Type: news

Serum Institute's Adar Poonawalla urges US to lift raw material export ban to ramp up vaccine production
SII is currently manufacturing anti-coronavirus vaccine Covishield, developed by AstraZeneca and Oxford University. The vaccine is not only being used in India, but exported to a number of countries. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - April 16, 2021 Category: Pharmaceuticals Source Type: news

Coronavirus: Study finds CVST blood clot risk is 10 times higher after Covid than after vaccination
An Oxford University study estimated 39 people out of a million develop cerebral venous sinus thrombosis (CVST) after having Covid-19, compared to four to five per million after a vaccine. (Source: the Mail online | Health)
Source: the Mail online | Health - April 15, 2021 Category: Consumer Health News Source Type: news

The data showed that about 4 in every 1 million people who get the American-made vaccines experience cerebral venous thrombosis (CVT),...
Research by Oxford University suggests all major vaccines carry a similar risk of rare clots, and all seem to have much lower risk than... (Source: Reuters: Health)
Source: Reuters: Health - April 15, 2021 Category: Consumer Health News Source Type: news

Study shows vaccines carry much lower risk of blood clots than COVID-19
Research by Oxford University suggests all major vaccines carry a similar risk of rare clots, and all seem to have much lower risk than... (Source: Reuters: Health)
Source: Reuters: Health - April 15, 2021 Category: Consumer Health News Source Type: news

Later school start times let students get adequate sleep
(Oxford University Press USA) A new study in SLEEP, published by Oxford University Press, demonstrates the significant benefits of later school start times for middle and high school students' sleep schedules. (Source: EurekAlert! - Social and Behavioral Science)
Source: EurekAlert! - Social and Behavioral Science - April 15, 2021 Category: International Medicine & Public Health Source Type: news

New paper shows how disease can affect economies for generations
(Oxford University Press USA) A new paper in the Review of Economic Studies finds that diseases can change the social networks and affect the economic growth of countries for generations. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - April 15, 2021 Category: International Medicine & Public Health Source Type: news

Apparently just by talking about it, I ’m super-spreading long Covid | George Monbiot
A professor has suggested that press coverage could make people believe they have the conditionRejoice! A mystery has been solved. We now have an explanation for long Covid, a condition afflictingmany thousands of people. A super-spreader has been identified. Important as this finding is, I ’m reluctant to call for the vector to be eradicated. Why? Because it’s me.Ina presentation to the reinsurance giant Swiss Re, Michael Sharpe, a professor of psychological medicine at the University of Oxford and founder of a long Covid clinic, proposed that one of the causes of the syndrome was “social factors”....
Source: Guardian Unlimited Science - April 14, 2021 Category: Science Authors: George Monbiot Tags: Long Covid Coronavirus Science UK news Source Type: news

Coronavirus UK: NHS to use £15 budesonide inhalers found to boost Covid recovery at home
A study led by the University of Oxford found that 32 per cent of people suffering from Covid at home recovered within two weeks if given the inhaler, compared to 22 per cent of people not given it. (Source: the Mail online | Health)
Source: the Mail online | Health - April 12, 2021 Category: Consumer Health News Source Type: news

AstraZeneca vaccine: Government to face compliance challenge if jab advice changes
ASTRAZENECA and Oxford University's Covid jab has suffered setbacks in the UK and Europe, where authorities have pushed for dose limitations after limited blood clot cases. Experts believe the pharmaceutical giant has "lost" the vaccine race in the UK, as the Government will struggle to regain public confidence. (Source: Daily Express - Health)
Source: Daily Express - Health - April 10, 2021 Category: Consumer Health News Source Type: news

Vaccitech warns of blood clot risk in IPO filing
Oxford university spinout behind AstraZeneca Covid-19 jab pushes ahead with US listing (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - April 9, 2021 Category: Pharmaceuticals Source Type: news

Two New Studies Point to How AstraZeneca ’s COVID-19 Vaccine Is Linked to Blood Clots
In two papers published in the New England Journal of Medicine (NEJM), researchers in Europe provide the most detailed explanation yet for what is behind the clotting side effects reported among people getting vaccinated with the AstraZeneca COVID-19 shot. In both papers, researchers found that people getting the vaccine had higher levels of antibodies directed against a cluster of immune-related cells that the body might form in response to the vaccine. These clusters include platelets, which help blood to clot when you get cut or injured, and the antibodies stick to the platelet-complex and form dangerous clots that can ...
Source: TIME: Health - April 9, 2021 Category: Consumer Health News Tags: Uncategorized COVID-19 Source Type: news

European Regulators Find Possible Link Between AstraZeneca COVID-19 Vaccine and Rare Clotting Disorder
(LONDON) — The European Union’s drug agency said Wednesday that it found a “possible link” between the AstraZeneca coronavirus vaccine and a rare clotting disorder but recommended that vaccinations continue in adults, saying the benefits of the shot still outweigh risks. The European Medicines Agency described the clots as “very rare” side effects. It said most of the cases reported have occurred in women under 60 within two weeks of vaccination — but based on the currently available evidence, it was not able to identify specific risk factors. Experts reviewed several dozen cases t...
Source: TIME: Health - April 7, 2021 Category: Consumer Health News Authors: MARIA CHENG/AP Tags: Uncategorized COVID-19 Source Type: news

Oxford Pauses COVID-19 Vaccine Study in Kids, Awaits More Data on Blood Clot Issues Oxford Pauses COVID-19 Vaccine Study in Kids, Awaits More Data on Blood Clot Issues
The University of Oxford said on Tuesday it had paused a small UK trial testing the COVID-19 vaccine it developed with AstraZeneca in children and teenagers.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - April 7, 2021 Category: Consumer Health News Tags: Pediatrics News Source Type: news

'Out-dated' social distancing measures will not protect you from Covid-19
Prof Trish Greenhalgh, a University of Oxford public health expert, was even more critical of many social-distancing measures claiming they are not effective in halting the transmission of Covid. (Source: the Mail online | Health)
Source: the Mail online | Health - April 3, 2021 Category: Consumer Health News Source Type: news

Virus Variants Threaten to Draw Out the Pandemic, Scientists Say
Declining infection rates over all masked a rise in more contagious forms of the coronavirus. Vaccines will stop the spread, if Americans postpone celebration just a bit longer. (Source: NYT Health)
Source: NYT Health - April 3, 2021 Category: Consumer Health News Authors: Apoorva Mandavilli and Benjamin Mueller Tags: your-feed-science Disease Rates Immune System Influenza Vaccination and Immunization Coronavirus (2019-nCoV) AstraZeneca PLC Johnson & Moderna Inc Novavax Inc Oxford University Pfizer Inc Brazil Europe Florida Germany Gre Source Type: news

AstraZeneca changes the name of its coronavirus vaccine after wave of blood clot deaths
(Natural News) Pharmaceutical giant AstraZeneca changed the name of its Wuhan coronavirus (COVID-19) vaccine following a string of controversies about its efficacy and several deaths. The vaccine developed by the Anglo-Swedish pharmaceutical company in cooperation with Oxford University is now called Vaxzevria. It was previously known simply as the AstraZeneca COVID-19 vaccine. The portal of the... (Source: NaturalNews.com)
Source: NaturalNews.com - April 1, 2021 Category: Consumer Health News Source Type: news

Oxford Nanopore float offers London a proper tech future
Planned IPO of life science group will test LSE ’s appetite for funding high-growth techOxford Nanopore to float on London Stock ExchangeAnother day, another tech float on the way for London. This one involves proper technology too: cutting-edge DNA sequencing and analytics, as opposed to takeaway food delivered by bicycle.Oxford Nanopore ’s likely arrival on the London Stock Exchange later this year is therefore very welcome. The UK market is short on life sciences companies capable of commanding multibillion-pound valuations.Let ’s not pretend, though, that the choice of London is some sort of national ...
Source: Guardian Unlimited Science - March 30, 2021 Category: Science Authors: Nils Pratley Tags: Technology sector Business Biometrics Nanotechnology Science Deliveroo IPOs Stock markets Coronavirus Industrial policy Steel industry Kwasi Kwarteng Politics University of Oxford Technology startups Source Type: news

Norwegian doctor says AstraZeneca jab is, in fact, causing deadly blood clots
(Natural News) As the world awaited a decision by the European Medicines Agency (EMA) as to the fate of the AstraZeneca and University of Oxford vaccine injection for the Wuhan coronavirus (Covid-19), a doctor in Norway had already determined it to be unsafe. Pal Andre Holme, a chief physician and professor, told Norwegian newspapers just... (Source: NaturalNews.com)
Source: NaturalNews.com - March 29, 2021 Category: Consumer Health News Source Type: news

REVEALED: Who ACTUALLY paid for the AstraZeneca vaccine to be developed amid EU scandal
ASTRAZENECA, with the help of partnered scientists at Oxford University, has created one of the world's most successful Covid jabs. But who really paid for the AstraZeneca vaccine to be developed? (Source: Daily Express - Health)
Source: Daily Express - Health - March 28, 2021 Category: Consumer Health News Source Type: news

How much AstraZeneca vaccine is made in the UK?
ASTRAZENECA, with the help of Oxford University, has made one of the most effective Covid vaccines on the market. How much AstraZeneca vaccine is made in the UK? (Source: Daily Express - Health)
Source: Daily Express - Health - March 27, 2021 Category: Consumer Health News Source Type: news

VAX FRAUD: AstraZeneca used outdated information to falsely claim fabricated efficacy of its coronavirus vaccine
(Natural News) Health officials publicly criticized AstraZeneca following reports that the pharmaceutical company used outdated information to show how well its coronavirus (COVID-19) vaccine worked. On Monday, March 22, AstraZeneca published reports stating that the vaccine it developed in partnership with Oxford University showed 79 percent efficacy in stopping symptomatic illness in trials conducted in... (Source: NaturalNews.com)
Source: NaturalNews.com - March 27, 2021 Category: Consumer Health News Source Type: news

Capitalism won't save us from Covid, no matter what Boris Johnson might think | Mariana Mazzucato
His claim that ‘greed’ was the driver behind the UK’s vaccine success ignores the huge role of state fundingBoris Johnson has attributed the UK ’s vaccine success to“capitalism” and “greed”. Though these were crude remarks, if the prime minister ’s words are any indication of his vision for how the UK can recover from the pandemic, there are worrying implications for the country’s policies at home and abroad.This is not the first time that Johnson has taken thewrong economic lessons from the Covid crisis. A few months agohe said in the same spirit that for “...
Source: Guardian Unlimited Science - March 27, 2021 Category: Science Authors: Mariana Mazzucato Tags: Coronavirus Vaccines and immunisation Science Research funding World news Infectious diseases Medical research Microbiology Boris Johnson Politics UK news Health Society Source Type: news

Covid UK: Oxford University to trial giving AstraZeneca vaccine as a nasal spray
Oxford University is looking for 30 adults to get the vaccine squirted up their noses as soon as next week. Volunteers will be tracked for four months to see make sure it's safe and works. (Source: the Mail online | Health)
Source: the Mail online | Health - March 26, 2021 Category: Consumer Health News Source Type: news

Coronavirus (COVID-19) Infection Survey, UK: 19 March 2021, ONS
Estimates for England, Wales, Northern Ireland, and Scotland. This survey is being delivered in partnership with University of Oxford, University of Manchester, Public Health England, and Wellcome Trust, updated 19th March 2021. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 25, 2021 Category: Consumer Health News Source Type: news

Centering Equity: A Vision for Global Health in 2021
COVID-19 has amplified the omission of disabled people. Credit: BigstockBy Shubha Nagesh and Sara RotenbergDEHRADUN, India/OXFORD, UK, Mar 24 2021 (IPS) 2020 will be remembered as the year that changed the world, as COVID-19 spared no country, no community, and no person. As the pandemic continues in 2021, there is recognition that some groups are impacted more than others, not just by the virus itself, but also by the socio-economic and access inequities exacerbated by global shutdowns. Globally, countries, and organisations are seeking to build back better and address inequities. António Guterres, Secretary-Genera...
Source: IPS Inter Press Service - Health - March 24, 2021 Category: International Medicine & Public Health Authors: Shubha Nagesh and Sara Rotenberg Tags: Global Headlines Health TerraViva United Nations Source Type: news

U.S. Health Officials Question AstraZeneca Vaccine Trial Results
According to federal officials, an independent panel of medical experts said the encouraging results announced on Monday might have relied on outdated information. (Source: NYT Health)
Source: NYT Health - March 24, 2021 Category: Consumer Health News Authors: Rebecca Robbins, Noah Weiland, Sharon LaFraniere and Benjamin Mueller Tags: Clinical Trials Drugs (Pharmaceuticals) Coronavirus (2019-nCoV) Vaccination and Immunization AstraZeneca PLC Food and Drug Administration National Institute of Allergy and Infectious Diseases Oxford University Source Type: news

AstraZeneca used ‘outdated and potentially misleading data’ that overstated the effectiveness of its vaccine, independent panel says
The company and Oxford University had announced Monday that a clinical trial in the United States, Chile and Peru showed 79 percent efficacy. (Source: Washington Post: To Your Health)
Source: Washington Post: To Your Health - March 23, 2021 Category: Consumer Health News Authors: Carolyn Y. Johnson Source Type: news

Spain gets set to lift restrictions for UK travellers on March 30
Figures compiled by the Oxford University-based research platform Our World in Data and analysed by MailOnline show 70 per cent of the EU saw infections rise in the past week. (Source: the Mail online | Health)
Source: the Mail online | Health - March 23, 2021 Category: Consumer Health News Source Type: news

Vaccine Safety Board Chides AstraZeneca for Using ‘Outdated’ Data in Press Release About its COVID-19 Shot
In an unusual move, on March 23 the U.S. National Institute of Allergy and Infectious Diseases (NIAID) issued a strongly worded statement asking AstraZeneca to “ensure the most accurate, up-to-date efficacy data be made public as quickly as possible.” On March 22, AstraZeneca released the results of its long-awaited U.S. trial of its COVID-19 vaccine, developed with scientists from Oxford University’s Jenner Institute. The data showed that the two-dose vaccine was 79% efficacious in protecting people from symptoms of COVID-19, and 100% efficacious in protecting against severe disease. That data, however, ...
Source: TIME: Health - March 23, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

AstraZeneca ’s U.S. Study May Answer Some of the Lingering Questions About Its Vaccine
This study puts to bed any doubts that this isn’t a highly effective vaccine against COVID-19 disease and COVID-19 symptoms,” says Mene Pangalos, executive vice president for biopharmaceuticals research and development at AstraZeneca. AstraZeneca’s vaccine is based on technology developed by scientists at Oxford University’s Jenner Institute, and involves using a chimpanzee adenovirus modified so it cannot cause the cold infection it normally does. The chimp virus acts as a vehicle to deliver genes into the body, where it encodes the SARS-CoV-2 spike protein; cells then process the protein so the im...
Source: TIME: Health - March 22, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Staggering graph shows how Covid hospital admissions are plummeting in Britain but soaring in the EU
Latest figures from the Oxford University-based research platform Our World in Data shows there were 106 Covid patients per million in British hospitals on March 15, down from 580 in January. (Source: the Mail online | Health)
Source: the Mail online | Health - March 22, 2021 Category: Consumer Health News Source Type: news

AstraZeneca Covid vaccine 79% effective with no increased blood clot risk – US trial
Study of 21,583 people included specific review of risks of cerebral venous sinus thrombosisCoronavirus – latest updatesSee all our coronavirus coverageAstraZeneca and Oxford University ’s Covid-19 vaccine was 79% effective in a large US trial into preventing symptomatic illness, and was 100% effective against severe or critical disease and hospitalisation, the drugmaker said on Monday.The fresh data comes after many countries resume use of the vaccine after the European Medicines Agency (EMA) and the World Health Organization (WHO) said the benefitsoutweighed the risks following investigations into reports of ...
Source: Guardian Unlimited Science - March 22, 2021 Category: Science Authors: Reuters Tags: Vaccines and immunisation Coronavirus US news World news Infectious diseases Medical research Health Source Type: news

AstraZeneca and Pfizer Covid vaccines more effective against Brazilian variant than initially feared
The Oxford University study found its vaccine and the jab made by Pfizer perform as well against the P.1 strain that first emerged in Manaus just as they do against the Kent variant. (Source: the Mail online | Health)
Source: the Mail online | Health - March 18, 2021 Category: Consumer Health News Source Type: news

Italy launches manslaughter case after AstraZeneca's coronavirus vaccine kills teacher
(Natural News) Prosecutors in Italy are launching a probe into the sudden death of a music teacher who died just hours after being injected with the Wuhan coronavirus (Covid-19) vaccine from AstraZeneca and the University of Oxford. According to reports, Sandro Tognatti, 57, was jabbed in his hometown of Biella on Saturday afternoon and very... (Source: NaturalNews.com)
Source: NaturalNews.com - March 18, 2021 Category: Consumer Health News Source Type: news

Women in cities less likely to have children
(Oxford University Press USA) A new study in Behavioral Ecology, published by Oxford University Press, finds that women are less likely to procreate in urban areas that have a higher percentage of females than males in the population. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 18, 2021 Category: International Medicine & Public Health Source Type: news

Some Mesothelioma Patients May Benefit from Second Radical Surgery
This study should elicit a call of hands for centers to share their experiences, to say either do it, or not do it,” Elsayed said. “Right now, you just don’t find a good number of centers doing that second operation.” Earlier Mesothelioma Surgery Studies  This most recent report focused on three smaller studies totaling 40 patients involved in a second major surgery with a curative intent for mesothelioma. In the first group of 16 patients, there was a median survival of 20.4 months after the second surgery for those with epithelial cell type, but only 7.4 months survival for those wit...
Source: Asbestos and Mesothelioma News - March 17, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Does AstraZeneca vaccine actually PREVENT blood clots? Experts point at bombshell stats
THE OXFORD University/AstraZeneca coronavirus vaccine has been suspended in several European countries over fears it can cause blood clots. However, according to the data, could the AstraZeneca vaccine actually prevent blood clots? (Source: Daily Express - Health)
Source: Daily Express - Health - March 16, 2021 Category: Consumer Health News Source Type: news

Why Countries Around the World Are Suspending Use of AstraZeneca ’s COVID-19 Vaccine
It’s the last thing public health officials want to see in the midst of a pandemic: more than two months after pharmaceutical giant AstraZeneca and Oxford University scientists released their COVID-19 vaccine, countries in Europe and elsewhere are pausing its use amid disconcerting reports that a small number of recipients have experienced blood clots, some of them fatal. The European Medicines Agency, which oversees drugs and vaccines in Europe, is expected to issue a guidance on March 18 about whether the side effects were related to the vaccine after reviewing the reports; in the meantime, it says the benefits of ...
Source: TIME: Health - March 16, 2021 Category: Consumer Health News Authors: Alice Park Tags: Uncategorized COVID-19 Source Type: news

Electronic cigarettes help smokers with schizophrenia quit
(Oxford University Press USA) A new study in Nicotine& Tobacco Research, published by Oxford University Press, finds that the use of high-strength nicotine e-cigarettes can help adults with schizophrenia spectrum disorders quit smoking. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 16, 2021 Category: International Medicine & Public Health Source Type: news

AstraZeneca Says Its COVID - 19 Vaccine Is Safe, Despite Reports of Deadly Clots
The AstraZeneca vaccine, developed with researchers from Oxford University, has been heavily used in Britain (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - March 16, 2021 Category: Cancer & Oncology Tags: Family Medicine, Geriatrics, Gynecology, Infections, Internal Medicine, Emergency Medicine, Nursing, Oncology, Pharmacy, Institutional, Source Type: news

Don Mason obituary
My friend and colleague Don Mason, who has died aged 86, will be remembered for his discoveries about cells of the body ’s immune system, notably the regulation of lymphocytes, and how fast and with what specificity their receptors recognise parts of foreign molecules.He began this work in 1973, joining the Medical Research Council ’s cellular immunology unit in the Dunn School of Pathology, Oxford University. He stayed for 26 years until his retirement in 1999, by which time he was its director.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - March 15, 2021 Category: Science Authors: Simon Hunt Tags: Immunology Medicine Diabetes Cancer research Medical research Veganism Source Type: news

Neanderthals helped create early human art, researcher says
Archaeologist says ability to think and create objects may not have been restricted to homo sapiensWhen Neanderthals, Denisovans and homo sapiens met one another 50,000 years ago, these archaic and modern humans not only interbred during the thousands of years in which they overlapped, but they exchanged ideas that led to a surge in creativity, according to a leading academic.Tom Higham, a professor of archaeological science at the University of Oxford, argues that their exchange explains “a proliferation of objects in the archaeological record”, such as perforated teeth and shell pendants, the use of pigments ...
Source: Guardian Unlimited Science - March 15, 2021 Category: Science Authors: Dalya Alberge Tags: Archaeology Anthropology Neanderthals Evolution Science University of Oxford Source Type: news

US Holds Millions of AstraZeneca Doses Requested Worldwide US Holds Millions of AstraZeneca Doses Requested Worldwide
Other countries that have authorized the AstraZeneca-University of Oxford vaccine are asking for the doses, which has become a major debate among White House and federal health officials.WebMD Health News (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - March 15, 2021 Category: Infectious Diseases Tags: Infectious Diseases News Source Type: news

AstraZeneca vaccine: Can I refuse to have the Oxford jab? Will they give me Pfizer instead
ASTRAZENECA and Oxford University collaborated on one of the most successful Covid vaccines, debuting their jab not long after Pfizer and Moderna. But as concerns over blood clots grow, can you refuse to have the AstraZeneca jab, and will they give you Pfizer instead? (Source: Daily Express - Health)
Source: Daily Express - Health - March 15, 2021 Category: Consumer Health News Source Type: news

Oxford University Hospital deploys blood analyser as part of COVID screening
The analyser is part of an assessment of the AI-based ‘CURIAL’ test to screen for COVID-19 in patients. (Source: mobihealthnews)
Source: mobihealthnews - March 15, 2021 Category: Information Technology Tags: Medical devices, Digital Health, Technology Source Type: news

New AJTMH supplement offers guidance on severe COVID-19 management in resource-limited settings
(Burness) A new supplement offering guidance on severe COVID-19 management in resource-limited settings is now available on the American Journal of Tropical Medicine (AJTMH) website. Pragmatic Recommendations for the Management of Hospitalized COVID-19 Patients in Low- and Middle-Income Countries was coordinated by a COVID-LMIC Task Force headed by Alfred Papali, MD, of Atrium Health, Charlotte, NC, and Marcus Schultz, MD, PhD, of Mahidol University, Bangkok, Thailand; University of Oxford, United Kingdom; and Amsterdam University Medical Centers, The Netherlands. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - March 12, 2021 Category: International Medicine & Public Health Source Type: news